Send to

Choose Destination
Trends Pharmacol Sci. 2012 Mar;33(3):146-53. doi: 10.1016/ Epub 2012 Jan 23.

Place your BETs: the therapeutic potential of bromodomains.

Author information

Epinova DPU, Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline PLC, Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK.


Therapeutic targeting of the processes that regulate histone modification is a growing area of scientific exploration. Although most interest has concentrated on the various families of enzymes that contribute to these processes, this review focuses on emerging data demonstrating the chemical tractability and therapeutic potential of a hitherto underexplored family of proteins, namely the bromodomain (BRD) family of reader proteins. These proteins perform a crucial role in translating histone modifications with powerful transcriptional consequences. We review current knowledge of the biology of this emergent target class and highlight recent breakthroughs that now make the BRD family of reader proteins attractive for drug discovery.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center